CoChat

Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR

Open access
Kimani, Martin M., Kern, Sara, Lanzarotta, Adam, Thatcher, Michael, Lorenz, Lisa M., Smith, Skyler W., Collins, Melissa, Howe, Gregory W., Wetherby, Anthony E. · 2023 · Drug Testing and Analysis
Cited by 23

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Developing methods to rapidly screen for novel synthetic 2‐benzylbenzimidazole opioids, also known as nitazenes, has become increasingly important due to their high potency. These compounds have potency comparable or exceeding that of fentanyl by up to 10 times and have been implicated in approximately 5% of all drug overdose deaths in the United States in 2021. This paper details the authenticity determination of suspect tablets and the identification of three nitazene analogs (N‐pyrrolidino etonitazene, isotonitazene, and etodesnitazene) in suspect tablets seized at a mail facility using Raman and surface‐enhanced Raman scattering (SERS) with handheld devices, portable Fourier transform infrared spectrometer (FT‐IR), and a direct analysis in real‐time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART‐TD‐MS). These methods are rapid and excellent for screening opioids in suspect tablets but could not fully determine the exact structure of some of the nitazene analogs present due to spectral similarities or similar fragmentation patterns. Liquid chromatography–mass spectrometry (LC–MS) confirmed the presence of these nitazene compounds in addition to other opioids/drugs that were in trace quantities. The quantitative high‐performance liquid chromatography coupled with ultraviolet (HPLC‐UV) detection experiments determined that the suspect tablets contained an average of 0.817 mg of N‐pyrrolidino etonitazene per tablet. The results obtained reveal that the simultaneous deployment of these complementary and orthogonal portable analytical techniques as part of a workflow allows suspect tablets to be screened and nitazene‐type drugs to be identified in suspect counterfeit tablets at remote sampling sites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dta.3440

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Kimani, M. M., Kern, S., Lanzarotta, A., Thatcher, M., Lorenz, L. M., Smith, S. W., Collins, M., Howe, G. W., & Wetherby, A. E.
Venue
Drug Testing and Analysis
Publisher
Wiley
Published
2023-02-05
Volume
15
Issue
5
Pages
539-550
ISSN
  • 1942-7603 (ISSN-L)
  • 1942-7611
OpenAlex
W4316928525
Cited by
23
References
9
FWCI
14.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.